HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Tomohiko Suzuki Selected Research

Toxocara canis TES-26 protein

9/2008Development of a highly sensitive IgG-ELISA based on recombinant arginine kinase of Toxocara canis for serodiagnosis of visceral larva migrans in the murine model.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Tomohiko Suzuki Research Topics

Disease

3Fibrosis (Cirrhosis)
03/2021 - 12/2007
2Non-alcoholic Fatty Liver Disease
03/2021 - 06/2015
2Infections
01/2017 - 09/2008
2Neuralgia (Stump Neuralgia)
03/2015 - 09/2014
2Pain (Aches)
03/2015 - 04/2004
2Hyperalgesia
09/2014 - 04/2004
1Syncope (Fainting)
03/2022
1Hematemesis
03/2022
1Parkinson Disease (Parkinson's Disease)
06/2021
1Insulin Resistance
03/2021
1Inflammation (Inflammations)
03/2021
1Alcoholic Fatty Liver
03/2021
1Liver Diseases (Liver Disease)
01/2018
1Neoplasms (Cancer)
04/2017
1Ascites
04/2017
1Neoplasm Metastasis (Metastasis)
04/2017
1Chronic Hepatitis B
01/2017
1Cysts
09/2016
1Schistosomiasis (Bilharziasis)
03/2014
1Visceral Larva Migrans
09/2008
1Toxocariasis
09/2008
1Liver Cirrhosis (Hepatic Cirrhosis)
12/2007
1Chronic Hepatitis C
12/2007
1Substance-Related Disorders (Drug Abuse)
10/2004

Drug/Important Bio-Agent (IBA)

2InterferonsIBA
04/2017 - 06/2015
2Interferon-betaIBA
01/2017 - 12/2007
2kappa Opioid Receptors (kappa Opioid Receptor)IBA
10/2004 - 04/2004
2TRK 820IBA
10/2004 - 04/2004
1NitrogenIBA
03/2022
1Urea (Carbamide)FDA LinkGeneric
03/2022
1Levodopa (L Dopa)FDA LinkGeneric
06/2021
1Carbidopa (Lodosyn)FDA LinkGeneric
06/2021
12- (2,5- difluorophenyl)- 5- (2- (methylsulfonyl)- 2,6- dihydropyrrolo(3,4- c)pyrazol- 5(4H)- yl)tetrahydro- 2H- pyran- 3- amineIBA
03/2021
1Transaminases (Aminotransferases)IBA
03/2021
1Aspartate Aminotransferases (Aspartate Transaminase)IBA
03/2021
1Dipeptidyl-Peptidase IV InhibitorsIBA
03/2021
1Hemoglobins (Hemoglobin)IBA
03/2021
1C-Reactive ProteinIBA
03/2021
1gamma-Glutamyltransferase (gamma-Glutamyl Transpeptidase)IBA
03/2021
1VaccinesIBA
01/2018
1Hepatitis B Surface Antigens (HBsAg)FDA Link
01/2017
1Antiviral Agents (Antivirals)IBA
01/2017
1Proteins (Proteins, Gene)FDA Link
09/2016
1Peptide Elongation Factor Tu (EF-Tu)IBA
09/2016
1PuromycinIBA
09/2016
1Amino AcidsFDA Link
06/2015
1Choline (Choline Chloride)IBA
06/2015
1Analgesics (Analgesic Drugs)IBA
03/2015
1GT-0198IBA
03/2015
1Glycine Plasma Membrane Transport ProteinsIBA
03/2015
1compound 20IBA
09/2014
1taurocyamine kinaseIBA
03/2014
1ImmunosorbentsIBA
09/2008
1Immunoglobulin G (IgG)IBA
09/2008
1EnzymesIBA
09/2008
1TESIBA
09/2008
1AntigensIBA
09/2008
1Arginine KinaseIBA
09/2008
1Toxocara canis TES-26 proteinIBA
09/2008
1Collagen Type I (Type I Collagen)IBA
12/2007
1Interferon Type IIBA
12/2007
1Hydroxyproline (4 Hydroxyproline)IBA
12/2007
1Concanavalin AIBA
12/2007
1Alanine Transaminase (SGPT)IBA
12/2007
1Transforming Growth Factor beta (TGF-beta)IBA
12/2007
1Fibroblast Growth Factor 2 (Basic Fibroblast Growth Factor)IBA
12/2007
1Tissue Inhibitor of Metalloproteinase-1IBA
12/2007
1Opioid Analgesics (Opioids)IBA
10/2004
1MorphinansIBA
04/2004
1enadolineIBA
04/2004
1mu Opioid Receptors (mu Opioid Receptor)IBA
04/2004
1Morphine (MS Contin)FDA LinkGeneric
04/2004

Therapy/Procedure

3Therapeutics
04/2017 - 12/2007
2Injections
12/2007 - 04/2004
1Spinal Injections
03/2015
1Ligation
03/2015
1Drug Therapy (Chemotherapy)
10/2004